← 產業報告目錄

3D Cell Culture Market by Product (Scaffolds [Hydrogels, Solid Scaffolds], Scaffold-free [Low Attachment Plates, Microfluidics, Bioprinted]), Application (Cancer, Stem Cell Research, Tissue Engineering), Trends, End User, Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-10-06頁數 323報告編號 BT4414

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global 3D cell culture market is projected to reach USD 2.26 billion by 2030 from USD 1.18 billion in 2024, at a CAGR of 11.7% during the forecast period. Factors such as increased adoption of 3D cell culture and a rise in funding for 3D cell culture research drive market growth. The scaffold-based 3D cell culture segment accounted for the highest market share in the product market. Based on the product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2024. Hydrogels/ECM analogs have emerged as the key contributor to segment growth. Increased demand for hydrogels is raising the focus of key market players on the development and launch of new products in the market. It is also biocompatible and non-toxic, making it ideal for use in research and drug development. The cancer and stem cell research segment accounted for the largest share of the application market in 2024. Based on the application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share in 2024. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment. The Asia Pacific region is likely to be the fastest-growing regional market. The 3D cell culture market is segmented into Europe, Asia Pacific, North America, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to be the fastest-growing regional segment during the forecast period. Growth in this market is attributed to the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries. The markets for biologics such as antibodies and protein-based drugs are also on the rise in the Asia Pacific region. Biotechnology-based drugs are anticipated to be one of the key drivers for the research industry due to increased research and government funds provided for these drugs. Global pharmaceutical firms are increasingly moving to Asia to tap into its thriving market and lower their production costs by shifting manufacturing to the region. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Tier 1- 25%, Tier 2- 35%, and Tier 3- 40% • By Designation: C-level Executives- 55%, Directors- 20%, and Others- 25% • By Region: North America- 45%, Europe- 20%, the Asia Pacific- 20%, Latin America- 10%, the Middle East- 3%, and Africa- 2% The top players in the global 3D cell culture market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Tecan Trading AG (Switzerland), Avantor, REPROCELL Inc. (Japan), 3D Biotek LLC. (US), S-BIO, Vaupell Holdings Inc. (US), Advanced BioMatrix Inc. (US), UPM Biomedicals (Finland), SYNTHECON, INCORPORATED (US), Emulate, Inc. (US), CN Bio Innovations Ltd. (UK), Kirkstall Ltd. (UK), Lena Biosciences (US), TissUse GmbH (Germany), Cellendes GmbH (Germany), Greiner Bio-one International GmbH (Germany), AMSBIO (UK), MIMETAS B.V.(Netherlands), and Promocell GmbH (Germany). Research Coverage This research report categorizes the 3D cell culture market by product (scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures), application (cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine), end user (pharmaceutical & biotechnology companies, research institutes, cosmetics industry, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the 3D cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, service portfolio, key strategies such as collaborations, partnerships, expansions, agreements, and acquisitions, and recent developments associated with the 3D cell culture market. This report covers a competitive analysis of top players and upcoming startups in the 3D cell culture market ecosystem. The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the 3D cell culture market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product launches, acquisitions, and recent developments associated with the 3D cell culture market. This report covers the competitive analysis of upcoming startups in the 3D cell culture market ecosystem. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (high focus on developing alternatives to animal testing, increasing adoption of personalized medicine, increased government support and funding, rising academia-research collaborations), restraints (high cost of implementing 3D cell culture technologies, lack of widely accepted or single standardization in 3D cell culture), opportunities (emergence of microfluidic based 3D cell culture), and challenges (lack of consistency in 3D cell culture products, high dependency on plastic waste disposals and consumables) influencing the growth of 3D cell culture market. • Product Development/Innovation: Detailed insights on newly launched products of the 3D cell culture market • Market Development: Comprehensive information about lucrative markets – the report analyses the 3D cell culture market across varied regions. • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D cell culture market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US), among others
目錄 Table of Contents
1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 MARKET SCOPE 33 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 33 1.3.2 INCLUSIONS AND EXCLUSIONS 33 1.3.3 YEARS CONSIDERED 34 1.4 CURRENCY CONSIDERED 34 1.5 STAKEHOLDERS 34 1.6 SUMMARY OF STRATEGIC CHANGES 35 2 RESEARCH METHODOLOGY 36 2.1 RESEARCH DATA 36 2.1.1 SECONDARY DATA 37 2.1.1.1 Key sources of secondary data 37 2.1.1.2 Key objectives of secondary research 37 2.1.2 PRIMARY DATA 38 2.1.2.1 Breakdown of primaries 38 2.1.2.2 Key objectives of primary research 39 2.2 MARKET SIZE ESTIMATION 39 2.2.1 GLOBAL MARKET SIZE ESTIMATION 39 2.2.1.1 Revenue share analysis (bottom-up approach) 40 2.2.1.2 Secondary data 41 2.2.1.3 Primary interviews and MnM repository analysis 42 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 42 2.2.3 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH) 43 2.3 GROWTH RATE PROJECTION 44 2.4 DATA TRIANGULATION 46 2.5 RESEARCH ASSUMPTIONS 47 2.6 RESEARCH LIMITATIONS 48 2.7 RISK ANALYSIS 48 3 EXECUTIVE SUMMARY 49 3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 49 3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS 51 3.3 DISRUPTIVE TRENDS SHAPING MARKET 51 3.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 51 3.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 52 4 PREMIUM INSIGHTS 53 4.1 UNMET NEEDS AND WHITE SPACES 53 4.2 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53 4.3 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFTS 53 4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 54 4.5 VC/PRIVATE EQUITY INVESTMENT TRENDS AND STARTUP LANDSCAPE 54 4.6 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 54 5 MARKET OVERVIEW 56 5.1 INTRODUCTION 56 5.2 MARKET DYNAMICS 56 5.2.1 DRIVERS 57 5.2.1.1 High focus on developing alternatives to animal testing 57 5.2.1.2 Growing shift toward personalized medicine 58 5.2.1.3 Integration of microphysiological systems and organ-on-chip platforms 59 5.2.2 RESTRAINTS 60 5.2.2.1 High costs of implementing 3D cell culture technologies 60 5.2.2.2 Absence of widely accepted or unified standards for experimental protocols 60 5.2.3 OPPORTUNITIES 61 5.2.3.1 High growth opportunities and booming biopharmaceutical sector in emerging economies 61 5.2.4 CHALLENGES 61 5.2.4.1 Lack of consistency in scaffold-based 3D cell culture products 61 5.2.4.2 High dependence on plastic waste disposals and consumables 62 5.3 TECHNOLOGY ANALYSIS 63 5.3.1 KEY TECHNOLOGIES 63 5.3.1.1 Microfluidics 63 5.3.1.2 Bioprinting 64 5.3.1.3 Organ-on-chip 64 5.3.2 COMPLEMENTARY TECHNOLOGIES 64 5.3.2.1 High-content imaging and automated microscopy 64 5.3.2.2 High-throughput screening platforms 65 5.3.3 ADJACENT TECHNOLOGIES 65 5.3.3.1 Magnetic levitation 65 5.3.3.2 Microfabrication 65   5.4 TRADE ANALYSIS 66 5.4.1 IMPORT DATA 66 5.4.2 EXPORT DATA 67 5.5 REGULATORY LANDSCAPE 69 5.5.1 REGULATORY FRAMEWORK 69 5.5.1.1 North America 69 5.5.1.2 Europe 69 5.5.1.3 Asia Pacific 70 5.5.1.4 Latin America 71 5.5.1.5 Middle East & Africa 71 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71 5.6 PORTER’S FIVE FORCES ANALYSIS 75 5.6.1 BARGAINING POWER OF SUPPLIERS 76 5.6.2 BARGAINING POWER OF BUYERS 76 5.6.3 THREAT OF NEW ENTRANTS 76 5.6.4 THREAT OF SUBSTITUTES 76 5.6.5 INTENSITY OF COMPETITIVE RIVALRY 77 5.7 IMPACT OF AI/GENERATIVE AI ON 3D CELL CULTURE MARKET 77 5.7.1 INTRODUCTION 77 5.7.2 MARKET POTENTIAL OF AI IN 3D CELL CULTURE APPLICATIONS 77 5.7.3 AI USE CASES 78 5.7.4 KEY COMPANIES IMPLEMENTING AI 78 5.7.5 FUTURE OF GENERATIVE AI IN 3D CELL CULTURE ECOSYSTEM 79 5.8 IMPACT OF 2025 US TARIFF ON 3D CELL CULTURE MARKET 79 5.8.1 INTRODUCTION 79 5.8.2 KEY TARIFF RATES 80 5.8.3 PRICE IMPACT ANALYSIS 81 5.8.4 IMPACT ON COUNTRY/REGION 81 5.8.4.1 US 81 5.8.4.2 Europe 82 5.8.4.3 Asia Pacific 82 5.8.5 IMPACT ON END-USE INDUSTRIES 83 5.8.5.1 Pharmaceutical and biotech companies 83 5.8.5.2 Hospitals and diagnostic laboratories 83 5.8.5.3 Academic and research institutes 84 5.8.5.4 Contract research organizations & contract development and manufacturing organizations 84   6 INDUSTRY TRENDS 85 6.1 PRICING ANALYSIS 85 6.1.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 85 6.1.2 AVERAGE SELLING PRICE TREND, BY REGION 88 6.2 PATENT ANALYSIS 90 6.2.1 METHODOLOGY 90 6.2.2 NUMBER OF PATENTS FILED 91 6.2.3 LIST OF KEY PATENTS 92 6.3 KEY CONFERENCES AND EVENTS, 2025–2026 93 6.4 INVESTMENT AND FUNDING SCENARIO 94 6.5 VALUE CHAIN ANALYSIS 95 6.6 ECOSYSTEM ANALYSIS 97 6.7 KEY STAKEHOLDERS AND BUYING CRITERIA 99 6.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 99 6.7.2 KEY BUYING CRITERIA 100 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 101 7 3D CELL CULTURE MARKET, BY TYPE 103 7.1 INTRODUCTION 104 7.2 SCAFFOLD-BASED 3D CELL CULTURES 104 7.2.1 HYDROGELS/ECM ANALOGS 108 7.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell culture market during forecast period 108 7.2.2 SOLID SCAFFOLDS 111 7.2.2.1 Growing adoption of solid scaffolds in regenerative medicine and preclinical in vitro testing to boost market 111 7.2.3 MICROPATTERNED SURFACES 115 7.2.3.1 Ability of micropatterned surfaces to enhance expression of enzyme levels and drug reactivity to drive growth 115 7.3 SCAFFOLD-FREE 3D CELL CULTURES 118 7.3.1 LOW-ATTACHMENT PLATES 122 7.3.1.1 Low-attachment plates to grow at highest rate in scaffold-free 3D cell cultures market 122 7.3.2 HANGING DROP PLATES 125 7.3.2.1 Growing use of hanging drop plates in stem cell differentiation and cytotoxicity research to propel growth 125 7.3.3 3D BIOREACTORS 129 7.3.3.1 Wide usage of 3D bioreactors in mass production of cells to support market growth 129 7.4 MICROFLUIDICS-BASED 3D CELL CULTURES 132 7.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE IN 3D CELL CULTURE MARKET DURING FORECAST PERIOD 132   7.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES 135 7.5.1 GROWING USE OF BIOPRINTING TECHNOLOGIES IN CANCER MODEL CREATION TO BOOST MARKET 135 8 3D CELL CULTURE MARKET, BY APPLICATION 139 8.1 INTRODUCTION 140 8.2 CANCER & STEM CELL RESEARCH 140 8.2.1 INCREASING DEMAND FOR PATIENT-DERIVED, AUTOMATED 3D ORGANOID SYSTEMS TO PROPEL MARKET 140 8.3 DRUG DISCOVERY & TOXICOLOGY TESTING 144 8.3.1 REGULATORY DEMAND AND TECHNOLOGICAL MATURATION OF PREDICTIVE 3D TOXICOLOGY MODELS TO DRIVE MARKET GROWTH 144 8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 147 8.4.1 ADVANCEMENTS IN BIOMATERIAL INNOVATION AND SCAFFOLD CUSTOMIZATION TO BOOST MARKET 147 8.5 3D CELL CULTURE MARKET, BY MODEL TYPE 151 9 3D CELL CULTURE MARKET, BY END USER 152 9.1 INTRODUCTION 153 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153 9.2.1 GROWING INTEGRATION OF 3D MODELS BY PHARMA AND BIOTECH COMPANIES TO DRIVE MARKET GROWTH 153 9.3 RESEARCH INSTITUTES 157 9.3.1 RESEARCH GRANTS FROM GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS TO AUGMENT MARKET 157 9.4 COSMETICS INDUSTRY 161 9.4.1 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET 161 9.5 OTHER END USERS 164 10 3D CELL CULTURE MARKET, BY REGION 168 10.1 INTRODUCTION 169 10.2 NORTH AMERICA 169 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 170 10.2.2 US 174 10.2.2.1 Product launches and capacity expansions to drive market growth 174 10.2.3 CANADA 176 10.2.3.1 Advancements in tissue therapeutics and regenerative medicine to boost market 176 10.3 EUROPE 179 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 179 10.3.2 GERMANY 182 10.3.2.1 Strategic acquisitions to fuel market growth 182 10.3.3 UK 185 10.3.3.1 Growing government funding and initiatives to propel market growth 185 10.3.4 FRANCE 187 10.3.4.1 Strategic collaborations to propel market growth 187 10.3.5 ITALY 190 10.3.5.1 Strong government support to enhance R&D activities 190 10.3.6 SPAIN 192 10.3.6.1 Strategic R&D investments and collaborative frameworks to drive market 192 10.3.7 REST OF EUROPE 195 10.4 ASIA PACIFIC 197 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 197 10.4.2 CHINA 201 10.4.2.1 Rising pharmaceutical R&D and investments to drive market growth 201 10.4.3 JAPAN 204 10.4.3.1 Strategic collaborations and technological advancements to augment market 204 10.4.4 INDIA 207 10.4.4.1 Strategic collaborations and infrastructure development to support market 207 10.4.5 SOUTH KOREA 209 10.4.5.1 Strategic investments and collaborations to propel market growth 209 10.4.6 AUSTRALIA 212 10.4.6.1 Advancements in 3D cell culture technologies to propel market 212 10.4.7 REST OF ASIA PACIFIC 214 10.5 LATIN AMERICA 217 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 218 10.5.2 BRAZIL 221 10.5.2.1 Rising prevalence of cancer and therapeutic development to support market 221 10.5.3 MEXICO 224 10.5.3.1 Growth in biopharmaceutical market to spur 3D cell culture demand 224 10.5.4 REST OF LATIN AMERICA 226 10.6 MIDDLE EAST 229 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 229 10.6.2 GCC COUNTRIES 232 10.6.2.1 Saudi Arabia 235 10.6.2.1.1 Strategic healthcare initiatives to drive market 235 10.6.2.2 UAE 238 10.6.2.2.1 Developments in healthcare infrastructure and growing government initiatives to drive market 238 10.6.2.3 Rest of GCC Countries 240 10.6.3 REST OF MIDDLE EAST 243   10.7 AFRICA 246 10.7.1 STRATEGIC COLLABORATIONS AND HEALTH INITIATIVES TO FUEL MARKET GROWTH 246 10.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 246 11 COMPETITIVE LANDSCAPE 250 11.1 INTRODUCTION 250 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 250 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN 3D CELL CULTURE MARKET 251 11.3 REVENUE ANALYSIS, 2020−2024 253 11.4 MARKET SHARE ANALYSIS, 2024 254 11.5 COMPANY VALUATION AND FINANCIAL METRICS 256 11.5.1 COMPANY VALUATION 256 11.5.2 FINANCIAL METRICS 257 11.6 BRAND/PRODUCT COMPARISON 257 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 258 11.7.1 STARS 258 11.7.2 EMERGING LEADERS 258 11.7.3 PERVASIVE PLAYERS 258 11.7.4 PARTICIPANTS 258 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 260 11.7.5.1 Company footprint 260 11.7.5.2 Region footprint 261 11.7.5.3 Product footprint 262 11.7.5.4 Application footprint 262 11.7.5.5 End-user footprint 263 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 264 11.8.1 PROGRESSIVE COMPANIES 264 11.8.2 RESPONSIVE COMPANIES 264 11.8.3 DYNAMIC COMPANIES 264 11.8.4 STARTING BLOCKS 264 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 266 11.8.5.1 Detailed list of key startups/SMEs 266 11.8.5.2 Competitive benchmarking of startups/SMEs 267 11.9 COMPETITIVE SCENARIO 268 11.9.1 PRODUCT LAUNCHES 268 11.9.2 DEALS 269 11.9.3 EXPANSIONS 270 11.9.4 OTHER DEVELOPMENTS 270   12 COMPANY PROFILES 271 12.1 KEY PLAYERS 271 12.1.1 THERMO FISHER SCIENTIFIC INC. 271 12.1.1.1 Business overview 271 12.1.1.2 Products offered 272 12.1.1.3 Recent developments 274 12.1.1.3.1 Product launches 274 12.1.1.3.2 Deals 274 12.1.1.3.3 Expansions 275 12.1.1.4 MnM view 276 12.1.1.4.1 Key strengths 276 12.1.1.4.2 Strategic choices 276 12.1.1.4.3 Weaknesses and competitive threats 276 12.1.2 MERCK KGAA 277 12.1.2.1 Business overview 277 12.1.2.2 Products offered 278 12.1.2.3 Recent developments 279 12.1.2.3.1 Deals 279 12.1.2.3.2 Expansions 280 12.1.2.4 MnM view 280 12.1.2.4.1 Key strengths 280 12.1.2.4.2 Strategic choices 280 12.1.2.4.3 Weaknesses and competitive threats 280 12.1.3 CORNING INCORPORATED 281 12.1.3.1 Business overview 281 12.1.3.2 Products offered 282 12.1.3.3 Recent developments 283 12.1.3.3.1 Product launches 283 12.1.3.4 MnM view 284 12.1.3.4.1 Key strengths 284 12.1.3.4.2 Strategic choices 284 12.1.3.4.3 Weaknesses and competitive threats 284 12.1.4 LONZA 285 12.1.4.1 Business overview 285 12.1.4.2 Products offered 286 12.1.4.3 Recent developments 287 12.1.4.3.1 Product launches 287 12.1.4.4 MnM view 287 12.1.4.4.1 Key strengths 287 12.1.4.4.2 Strategic choices 287 12.1.4.4.3 Weaknesses and competitive threats 287   12.1.5 AVANTOR, INC. 288 12.1.5.1 Business overview 288 12.1.5.2 Products offered 289 12.1.6 TECAN TRADING AG 290 12.1.6.1 Business overview 290 12.1.6.2 Products offered 291 12.1.6.3 MnM view 292 12.1.6.3.1 Key strengths 292 12.1.6.3.2 Strategic choices 292 12.1.6.3.3 Weaknesses and competitive threats 292 12.1.7 REPROCELL INC. 293 12.1.7.1 Business overview 293 12.1.7.2 Products offered 293 12.1.7.3 Recent developments 295 12.1.7.3.1 Deals 295 12.1.8 3D BIOTEK LLC 296 12.1.8.1 Business overview 296 12.1.8.2 Products offered 296 12.1.9 EMULATE, INC. 297 12.1.9.1 Business overview 297 12.1.9.2 Products offered 297 12.1.9.3 Recent developments 298 12.1.9.3.1 Product launches 298 12.1.10 SYNTHECON, INCORPORATED 299 12.1.10.1 Business overview 299 12.1.10.2 Products offered 299 12.1.11 INSPHERO 301 12.1.11.1 Business overview 301 12.1.11.2 Products offered 301 12.1.11.3 Recent developments 302 12.1.11.3.1 Deals 302 12.1.11.3.2 Other developments 302 12.1.12 KIRKSTALL LTD. 303 12.1.12.1 Business overview 303 12.1.12.2 Products offered 303 12.1.13 GREINER BIO-ONE INTERNATIONAL GMBH 304 12.1.13.1 Business overview 304 12.1.13.2 Products offered 304 12.1.14 PROMOCELL GMBH 305 12.1.14.1 Business overview 305 12.1.14.2 Products offered 305   12.1.15 UPM 306 12.1.15.1 Business overview 306 12.1.15.2 Products offered 306 12.2 OTHER PLAYERS 307 12.2.1 CN BIO INNOVATIONS LTD. 307 12.2.2 TISSUSE GMBH 308 12.2.3 LENA BIOSCIENCES 309 12.2.4 CELLENDES GMBH 310 12.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO) 311 12.2.6 SYNVIVO, INC. 312 12.2.7 AMS BIOTECHNOLOGY (EUROPE) LTD 313 12.2.8 MIMETAS B.V. 314 12.2.9 S-BIO, VAUPELL HOLDINGS INC. 315 12.2.10 NANOFIBER SOLUTIONS 315 13 APPENDIX 316 13.1 DISCUSSION GUIDE 316 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 319 13.3 CUSTOMIZATION OPTIONS 321 13.4 RELATED REPORTS 321 13.5 AUTHOR DETAILS 322
圖表清單 List of Tables & Figures
TABLE 1 3D CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS 33 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 45 TABLE 3 3D CELL CULTURE MARKET: RISK ANALYSIS 48 TABLE 4 3D CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 57 TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS 62 TABLE 6 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE 63 TABLE 7 IMPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND) 66 TABLE 8 IMPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 67 TABLE 9 EXPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND) 67 TABLE 10 EXPORT DATA FOR HS CODE 382100, 2020–2024 (TONS) 68 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74 TABLE 15 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 76 TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 80 TABLE 17 3D CELL CULTURE PRODUCTS-RELATED TARIFF REVISION 81 TABLE 18 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS 83 TABLE 19 AVERAGE SELLING PRICE TREND OF 3D CELL CULTURE PRODUCTS, BY KEY PLAYER, 2022–2024 (USD MILLION) 85 TABLE 20 AVERAGE SELLING PRICE TREND OF EQUIPMENT, BY REGION, 2022–2024 (USD MILLION) 88 TABLE 21 AVERAGE SELLING PRICE TREND OF KITS, BY REGION, 2022–2024 (USD MILLION) 88 TABLE 22 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION, 2022–2024 (USD MILLION) 88 TABLE 23 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 91 TABLE 24 LIST OF KEY PATENTS IN 3D CELL CULTURE MARKET, 2023–2025 92 TABLE 25 3D CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, JANUARY 2025–DECEMBER 2026 93 TABLE 26 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO OF KEY PLAYERS, 2022−2025 94 TABLE 27 3D CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 98 TABLE 28 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER 100 TABLE 29 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 104 TABLE 30 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 105 TABLE 31 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 32 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 33 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 34 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 35 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 36 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 37 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 38 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 39 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 40 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 41 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 42 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 43 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 44 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR HYDROGELS/ECM ANALOGS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 45 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 46 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 47 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 48 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 49 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 50 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 51 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 52 SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 53 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 54 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 55 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 56 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 57 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 58 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 59 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 118 TABLE 60 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 61 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 62 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 63 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 64 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 65 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 66 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 67 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 68 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 69 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 70 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 71 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 72 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 73 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR LOW-ATTACHMENT PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 74 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 75 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 76 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 77 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 78 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 79 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 80 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR HANGING DROP PLATES, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 81 SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 82 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 83 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 84 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 85 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 86 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 87 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET FOR 3D BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 88 MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 89 NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 90 EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 91 ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 92 LATIN AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 93 MIDDLE EAST: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 94 GCC COUNTRIES: MICROFLUIDICS-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 95 MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 96 NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 97 EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 98 ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 99 LATIN AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 100 MIDDLE EAST: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 101 GCC COUNTRIES: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 102 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 103 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 104 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 105 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 106 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 107 LATIN AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 108 MIDDLE EAST: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 109 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 110 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 111 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 112 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 113 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 114 LATIN AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 115 MIDDLE EAST: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 116 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 117 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 118 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 119 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 120 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 121 LATIN AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 122 MIDDLE EAST: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 123 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 124 3D CELL CULTURE MARKET, BY MODEL TYPE, 2023–2030 (USD MILLION) 151 TABLE 125 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 126 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 127 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 128 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 129 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 130 LATIN AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 131 MIDDLE EAST: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 132 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 133 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 134 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 135 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 136 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 137 LATIN AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 138 MIDDLE EAST: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 139 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 140 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 141 NORTH AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 142 EUROPE: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 143 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 144 LATIN AMERICA: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 145 MIDDLE EAST: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 146 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 147 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 148 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 149 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 150 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 151 LATIN AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 152 MIDDLE EAST: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 153 GCC COUNTRIES: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 154 3D CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 155 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 156 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 157 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 158 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 159 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 160 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 161 US: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 162 US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 163 US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 164 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 165 US: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 166 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 167 CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 168 CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 169 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178 TABLE 170 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 172 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 173 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 174 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 175 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 181 TABLE 176 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 182 TABLE 177 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 178 GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 179 GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 180 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184 TABLE 181 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 182 UK: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 183 UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 184 UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 185 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 186 TABLE 186 UK: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 187 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 188 FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 189 FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 190 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 189 TABLE 191 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 189 TABLE 192 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 193 ITALY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 194 ITALY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 195 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 191 TABLE 196 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 197 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 198 SPAIN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 199 SPAIN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 200 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 194 TABLE 201 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 194 TABLE 202 REST OF EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 203 REST OF EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 204 REST OF EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 205 REST OF EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 196 TABLE 206 REST OF EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 207 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 208 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 209 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 210 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 211 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 200 TABLE 212 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 213 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 214 CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 215 CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 216 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 203 TABLE 217 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 218 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 219 JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 220 JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 221 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 206 TABLE 222 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 223 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 224 INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 225 INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 226 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 208 TABLE 227 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 228 SOUTH KOREA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 229 SOUTH KOREA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 230 SOUTH KOREA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 231 SOUTH KOREA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 211 TABLE 232 SOUTH KOREA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 233 AUSTRALIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 234 AUSTRALIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 235 AUSTRALIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 236 AUSTRALIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213 TABLE 237 AUSTRALIA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 214 TABLE 238 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 239 REST OF ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 240 REST OF ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 241 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 216 TABLE 242 REST OF ASIA PACIFIC: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 243 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 244 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 245 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 246 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 247 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 220 TABLE 248 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 249 BRAZIL: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 250 BRAZIL: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 251 BRAZIL: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 252 BRAZIL: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 223 TABLE 253 BRAZIL: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 254 MEXICO: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 255 MEXICO: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 256 MEXICO: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 257 MEXICO: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225 TABLE 258 MEXICO: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 259 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 260 REST OF LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 261 REST OF LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 262 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 228 TABLE 263 REST OF LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 229 TABLE 264 MIDDLE EAST: 3D CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 265 MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 266 MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 267 MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 268 MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 232 TABLE 269 MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 232 TABLE 270 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 271 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 272 GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 273 GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 274 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 234 TABLE 275 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 235 TABLE 276 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 277 SAUDI ARABIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 278 SAUDI ARABIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 279 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 237 TABLE 280 SAUDI ARABIA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 281 UAE: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 282 UAE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 283 UAE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 284 UAE: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 240 TABLE 285 UAE: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 240 TABLE 286 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 287 REST OF GCC COUNTRIES: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 288 REST OF GCC COUNTRIES: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 289 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 242 TABLE 290 REST OF GCC COUNTRIES: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 291 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 292 REST OF MIDDLE EAST: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 293 REST OF MIDDLE EAST: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 294 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 295 REST OF MIDDLE EAST: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 296 AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 297 AFRICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 298 AFRICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 299 AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 248 TABLE 300 AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 301 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022−SEPTEMBER 2025 251 TABLE 302 3D CELL CULTURE MARKET: DEGREE OF COMPETITION 255 TABLE 303 3D CELL CULTURE MARKET: REGION FOOTPRINT 261 TABLE 304 3D CELL CULTURE MARKET: PRODUCT FOOTPRINT 262 TABLE 305 3D CELL CULTURE MARKET: APPLICATION FOOTPRINT 262 TABLE 306 3D CELL CULTURE MARKET: END-USER FOOTPRINT 263 TABLE 307 3D CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 266 TABLE 308 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 267 TABLE 309 3D CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 268 TABLE 310 3D CELL CULTURE MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 269 TABLE 311 3D CELL CULTURE MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 270 TABLE 312 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 270 TABLE 313 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 271 TABLE 314 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 272 TABLE 315 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 274 TABLE 316 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 274 TABLE 317 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 275 TABLE 318 MERCK KGAA: COMPANY OVERVIEW 277 TABLE 319 MERCK KGAA: PRODUCTS OFFERED 278 TABLE 320 MERCK KGAA: DEALS, JANUARY 2022–SEPTEMBER 2025 279 TABLE 321 MERCK KGAA: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 280 TABLE 322 CORNING INCORPORATED: COMPANY OVERVIEW 281 TABLE 323 CORNING INCORPORATED: PRODUCTS OFFERED 282 TABLE 324 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 283 TABLE 325 LONZA: COMPANY OVERVIEW 285 TABLE 326 LONZA: PRODUCTS OFFERED 286 TABLE 327 LONZA: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 287 TABLE 328 AVANTOR, INC.: COMPANY OVERVIEW 288 TABLE 329 AVANTOR, INC.: PRODUCTS OFFERED 289 TABLE 330 TECAN TRADING AG: COMPANY OVERVIEW 290 TABLE 331 TECAN TRADING AG: PRODUCTS OFFERED 291 TABLE 332 REPROCELL INC.: COMPANY OVERVIEW 293 TABLE 333 REPROCELL INC.: PRODUCTS OFFERED 293 TABLE 334 REPROCELL INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 295 TABLE 335 3D BIOTEK LLC: COMPANY OVERVIEW 296 TABLE 336 3D BIOTEK LLC: PRODUCTS OFFERED 296 TABLE 337 EMULATE, INC.: COMPANY OVERVIEW 297 TABLE 338 EMULATE, INC.: PRODUCTS OFFERED 297 TABLE 339 EMULATE, INC.: PRODUCT LAUNCHES, JANUARY 2022–SEPTEMBER 2025 298 TABLE 340 SYNTHECON, INCORPORATED: COMPANY OVERVIEW 299 TABLE 341 SYNTHECON, INCORPORATED: PRODUCTS OFFERED 299 TABLE 342 INSPHERO: COMPANY OVERVIEW 301 TABLE 343 INSPHERO: PRODUCTS OFFERED 301 TABLE 344 INSPHERO: DEALS, JANUARY 2022–SEPTEMBER 2025 302 TABLE 345 INSPHERO: OTHER DEVELOPMENTS, JANUARY 2022–SEPTEMBER 2025 302 TABLE 346 KIRKSTALL LTD.: COMPANY OVERVIEW 303 TABLE 347 KIRKSTALL LTD.: PRODUCTS OFFERED 303 TABLE 348 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW 304 TABLE 349 GREINER BIO-ONE INTERNATIONAL GMBH: PRODUCTS OFFERED 304 TABLE 350 PROMOCELL GMBH: COMPANY OVERVIEW 305 TABLE 351 PROMOCELL GMBH: PRODUCTS OFFERED 305 TABLE 352 UPM: COMPANY OVERVIEW 306 TABLE 353 UPM: PRODUCTS OFFERED 306 TABLE 354 CN BIO INNOVATIONS LTD.: COMPANY OVERVIEW 307 TABLE 355 TISSUSE GMBH: COMPANY OVERVIEW 308 TABLE 356 LENA BIOSCIENCES: COMPANY OVERVIEW 309 TABLE 357 CELLENDES GMBH: COMPANY OVERVIEW 310 TABLE 358 ADVANCED BIOMATRIX, INC.: COMPANY OVERVIEW 311 TABLE 359 SYNVIVO, INC.: COMPANY OVERVIEW 312 TABLE 360 AMS BIOTECHNOLOGY (EUROPE) LTD: COMPANY OVERVIEW 313 TABLE 361 MIMETAS B.V.: COMPANY OVERVIEW 314 TABLE 362 S-BIO, VAUPELL HOLDINGS INC.: COMPANY OVERVIEW 315 TABLE 363 NANOFIBER SOLUTIONS: COMPANY OVERVIEW 315 FIGURE 1 3D CELL CULTURE MARKET SEGMENTATION AND REGIONAL SCOPE 33 FIGURE 2 3D CELL CULTURE MARKET: RESEARCH DESIGN 36 FIGURE 3 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS) 38 FIGURE 4 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 39 FIGURE 5 3D CELL CULTURE MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2024 40 FIGURE 6 COMPANY REVENUE ANALYSIS: ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC., 2024 41 FIGURE 7 3D CELL CULTURE MARKET: INSIGHTS FROM PRIMARY EXPERTS 42 FIGURE 8 3D CELL CULTURE SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 43 FIGURE 9 3D CELL CULTURE MARKET: CAGR PROJECTIONS 44 FIGURE 10 3D CELL CULTURE MARKET: DATA TRIANGULATION 46 FIGURE 11 3D CELL CULTURE MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 49 FIGURE 12 3D CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 50 FIGURE 13 3D CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50 FIGURE 14 HIGH FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET 52 FIGURE 15 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56 FIGURE 16 3D CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS 75 FIGURE 17 AI USE CASES 78 FIGURE 18 AVERAGE SELLING PRICE OF EQUIPMENT, BY KEY PLAYER, 2024 (USD) 86 FIGURE 19 AVERAGE SELLING PRICE OF KITS, BY KEY PLAYER, 2024 (USD) 87 FIGURE 20 AVERAGE SELLING PRICE OF REAGENTS, BY KEY PLAYER, 2024 (USD) 87 FIGURE 21 AVERAGE SELLING PRICE OF EQUIPMENT, BY REGION, 2024 (USD MILLION) 89 FIGURE 22 AVERAGE SELLING PRICE OF KITS, BY REGION, 2024 (USD MILLION) 89 FIGURE 23 AVERAGE SELLING PRICE OF REAGENTS, BY REGION, 2024 (USD MILLION) 90 FIGURE 24 3D CELL CULTURE MARKET: PATENT ANALYSIS, JANUARY 2014–DECEMBER 2024 91 FIGURE 25 3D CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO, 2022–2025 (USD MILLION) 95 FIGURE 26 3D CELL CULTURE MARKET: VALUE CHAIN ANALYSIS 95 FIGURE 27 3D CELL CULTURE MARKET: ECOSYSTEM ANALYSIS 97 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS 99 FIGURE 29 KEY BUYING CRITERIA, BY END USER 100 FIGURE 30 NEW REVENUE POCKETS FOR PLAYERS IN 3D CELL CULTURE MARKET 102 FIGURE 31 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT 171 FIGURE 32 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT 198 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET, 2020−2024 (USD MILLION) 253 FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN 3D CELL CULTURE MARKET, 2024 254 FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 256 FIGURE 36 EV/EBITDA OF KEY VENDORS 257 FIGURE 37 3D CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON 257 FIGURE 38 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 259 FIGURE 39 3D CELL CULTURE MARKET: COMPANY FOOTPRINT 260 FIGURE 40 3D CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 265 FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 272 FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2024) 278 FIGURE 43 CORNING INCORPORATED: COMPANY SNAPSHOT (2024) 282 FIGURE 44 LONZA: COMPANY SNAPSHOT (2024) 286 FIGURE 45 AVANTOR, INC: COMPANY SNAPSHOT (2024) 289 FIGURE 46 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 291

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們